General Home Investors News

Clinical trial conducted by MedinCell confirms the safety of continuous administration of ivermectin

By MedincellApril 19, 2021March 15th, 2024No Comments

Clinical trial conducted by MedinCell confirms the safety of continuous administration of ivermectin

April 19, 2021

Previous PostVideoconference and publication of the results for the 2020-2021 financial year, on June 16, 2021
Next PostMedinCell: mdc-CWM clinical phase 3 will start in 2021

Better medicine for all

Website by ScreenUp